Stocklytics score rationale: value 36, quality 50, growth 36.
Financials
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
7515000000
7709000000
7531000000
7726000000
9437000000
10788000000
9883000000
9252000000
9872000000
11035000000
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily…
Forecast
Consensus Buy from 18 analysts. Average price target $256.17, +2.6% versus the current price. Low $245.00. High $262.00.
Analysts have an average 12-month price target of $256.17 for Quest Diagnostics (DGX), 2.4% above the current price of $250.12. Of 18 analysts covering the stock, 9 rate it Buy or Strong Buy, 8 Hold, and 1 Sell or Strong Sell, giving a consensus of Buy.
Forecasts are third-party estimates and often wrong. They are not investment advice.
DGX price target
12-month price target
Low
$245.00
Average
$256.17
High
$262.00
The average is 2.4% above the current price of $250.12.
Is Quest Diagnostics a buy or sell?
Of 18 analysts, 9 rate Quest Diagnostics Buy or Strong Buy, 8 Hold, and 1 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.
The Stocklytics Score for DGX is 41 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
DGX forecast FAQs
What is the DGX price target?
$256.17 average, with a published range of $245.00 to $262.00.
Is Quest Diagnostics a buy or sell?
The consensus is Buy from 18 analysts. This is not a recommendation.
What is the Quest Diagnostics stock forecast for 2026?
Analysts' average EPS estimate for 2026 on file is $11.31. The average revenue estimate is $12.08 billion.
What will DGX be worth in 2030?
No reliable forecast exists that far out.
When is Quest Diagnostics's next earnings report?
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.